Related Experiment Video
Updated: Jun 21, 2026

Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
Published on: March 7, 2022
Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60
Huarong Tang1, Fangping Chen, Qian Tan
1Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China.
Abstract:
Polycomb repressive complex 2 (PRC2), which mediates trimethylation of lysine 27 on histone H3 (K27me3), plays an important role in many types of stem cell differentiation. Here, we try to reveal how PRC2, PRC2-mediated repressive histone marker H3K27me3, and active histone marker histone H4 acetylation (acH4) regulate the CD11b transcription during alltrans retinoic acid (ATRA)-induced HL-60 leukemia cell differentiation. By using quantitative real-time polymerase chain reaction (qPCR) and western blot analysis, we found that the mRNA and protein expression levels of two members of PRC2 were decreased during ATRA-induced HL-60 differentiation, respectively. When treated with ATRA for 72 h, the EZH2 and SUZ12 mRNA levels were decreased to 35% and 38% of the control group, respectively. At the same time, the granulocytic mature surface marker CD11b expression was increased significantly at mRNA level detected by qPCR and protein level detected by flow cytometry. By using chromatin immunoprecipitation assay, we compared the local changes in SUZ12 binding and PRC2-mediated H3K27me3 at the promoter of CD11b during ATRA-induced HL-60 differentiation. Both the levels of SUZ12 binding and PRC2-mediated H3K27me3 at the promoter of CD11b were decreased for 4.1 and 3.8 folds, respectively. And we also found the increase in the acH4 level up to 4 folds after 72 h of ATRA treatment. These results suggested that the histone modification including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4 may involve in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation.
Insights
Polycomb repressive complex 2 (PRC2) and its H3K27me3 mark decrease during ATRA-induced HL-60 cell differentiation, correlating with increased CD11b expression and histone H4 acetylation.
Area of Science:
- Epigenetics
- Molecular Biology
- Cell Differentiation
Background:
- Polycomb repressive complex 2 (PRC2) is crucial for stem cell differentiation via histone H3 lysine 27 trimethylation (H3K27me3).
- Understanding epigenetic regulation of gene transcription is vital for leukemia cell differentiation research.
Purpose of the Study:
- To investigate the roles of PRC2, H3K27me3, and histone H4 acetylation (acH4) in CD11b transcription during all-trans retinoic acid (ATRA)-induced HL-60 leukemia cell differentiation.
- To elucidate the molecular mechanisms underlying HL-60 cell reprogramming.
Main Methods:
- Quantitative real-time polymerase chain reaction (qPCR) to measure mRNA levels.
- Western blot analysis for protein expression.
- Chromatin immunoprecipitation (ChIP) assay to assess protein binding and histone modifications.
- Flow cytometry to detect cell surface marker expression.
Main Results:
- PRC2 components (EZH2, SUZ12) mRNA and protein levels decreased significantly during ATRA treatment.
- CD11b expression, a granulocytic marker, increased at both mRNA and protein levels.
- ChIP assays revealed decreased SUZ12 binding and H3K27me3 at the CD11b promoter.
- Histone H4 acetylation (acH4) levels at the CD11b promoter increased significantly.
Conclusions:
- PRC2 activity and H3K27me3 are downregulated during ATRA-induced HL-60 differentiation.
- Decreased H3K27me3 and increased acH4 at the CD11b promoter are associated with CD11b gene activation.
- These histone modifications play a role in the terminal differentiation of HL-60 leukemia cells.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Master Transcription Regulators
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Differentiation of Common Myeloid Progenitor Cells
